Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-14

FDA Approved: ETRAVIRINE — Original Application (AvKARE)

View source ↗

Summary

The FDA approved AvKARE's original application for etravirine, a NNRTI used in combination with other antiretrovirals to treat HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • etravirine (etravirine)

Snippet

ORIG AP for ETRAVIRINE (ETRAVIRINE)